148 related articles for article (PubMed ID: 15248822)
1. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.
Yamashita H; Yamashita T; Miyamoto M; Shigematsu T; Kazama JJ; Shimada T; Yamazaki Y; Fukumoto S; Fukagaw M; Noguchi S
Eur J Endocrinol; 2004 Jul; 151(1):55-60. PubMed ID: 15248822
[TBL] [Abstract][Full Text] [Related]
2. Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.
Kobayashi K; Imanishi Y; Miyauchi A; Onoda N; Kawata T; Tahara H; Goto H; Miki T; Ishimura E; Sugimoto T; Ishikawa T; Inaba M; Nishizawa Y
Eur J Endocrinol; 2006 Jan; 154(1):93-9. PubMed ID: 16381997
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
Shigematsu T; Kazama JJ; Yamashita T; Fukumoto S; Hosoya T; Gejyo F; Fukagawa M
Am J Kidney Dis; 2004 Aug; 44(2):250-6. PubMed ID: 15264182
[TBL] [Abstract][Full Text] [Related]
5. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-23 in patients with Graves' disease before and after antithyroid therapy: its important role in serum phosphate regulation.
Yamashita H; Yamazaki Y; Hasegawa H; Yamashita T; Fukumoto S; Shigematsu T; Kazama JJ; Fukagawa M; Noguchi S
J Clin Endocrinol Metab; 2005 Jul; 90(7):4211-5. PubMed ID: 15827108
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
Tebben PJ; Singh RJ; Clarke BL; Kumar R
Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
[TBL] [Abstract][Full Text] [Related]
9. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
[TBL] [Abstract][Full Text] [Related]
10. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
Piovesan A; Molineri N; Casasso F; Emmolo I; Ugliengo G; Cesario F; Borretta G
Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
[TBL] [Abstract][Full Text] [Related]
12. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
Boudou P; Ibrahim F; Cormier C; Sarfati E; Souberbielle JC
J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor-23 and Vitamin D Metabolism in Subjects with eGFR ≥60 ml/min/1.73 m².
Nakatani S; Nakatani A; Tsugawa N; Yamada S; Mori K; Imanishi Y; Ishimura E; Okano T; Inaba M
Nephron; 2015; 130(2):119-26. PubMed ID: 26068724
[TBL] [Abstract][Full Text] [Related]
14. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?
Witteveen JE; van Lierop AH; Papapoulos SE; Hamdy NA
Eur J Endocrinol; 2012 Jan; 166(1):55-60. PubMed ID: 21984611
[TBL] [Abstract][Full Text] [Related]
17. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum parathyroid hormone concentration in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism and its relationship to vitamin D profile.
Dhillon KS; Cohan P; Darwin C; Van Herle A; Chopra IJ
Metabolism; 2004 Sep; 53(9):1101-6. PubMed ID: 15334367
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Sprague SM; Wetmore JB; Gurevich K; Da Roza G; Buerkert J; Reiner M; Goodman W; Cooper K
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1021-30. PubMed ID: 25873267
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
